Clobutinol
- Level
- Commodity
- Parent
- 51162600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51162615This classification denotes an antitussive agent with the molecular formula C14H22ClNO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 1NY2IX043A, chemically known as 1-(4-chlorophenyl)-2,3-dimethyl-4-dimethylamino-2-butanol but more generally known as clobutinol, which bears US NIH Compound Identifier 26937. European Medicines Agency schedules Clobutinol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06680MIG. The term CLOBUTINOL is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 22, No. 10, 1968, List 8). World Health Organization schedules clobutinol in its Anatomical Therapeutic Chemical (ATC) Classification. CLOBUTINOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule clobutinol under HS 29221980 and SITC 51461. As of Q4 2014, CLOBUTINOL remains US FDA's Preferred Term for this commodity. Clobutinol bears US NLM identifiers UMLS ID C0055897 and NCI Concept Code C78105. SMILES: CLC1CCC(CC(O)(C(CN(C)C)C)C)CC1.
Same parent
Under 51162600 · 55Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.